Frontier Biotechnologies Inc. (688221.SH) has announced its 2025 Restricted Stock Incentive Plan (Draft), proposing to grant 5 million restricted shares to eligible participants, representing approximately 1.33% of the company's total share capital as of the draft plan's announcement date. The plan includes an initial grant of 4.25 million restricted shares and reserves 750,000 shares for future allocation. The grant price for the initial restricted shares is set at 8.56 yuan per share. The incentive plan will remain effective from the grant date of the restricted shares until all granted shares are either vested or expire, with a maximum duration not exceeding 36 months.
Comments